• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    Zogenix, Inc. (ZGNX)

    -NasdaqGM
    1.25 Up 0.05(4.17%) Dec 26, 3:59PM EST
    |After Hours : 1.25 0.00 (0.00%) Dec 26, 4:52PM EST
    Add to Portfolio
    Prev Close:1.20
    Open:1.20
    Bid:N/A
    Ask:1.45 x 1000
    1y Target Est:2.81
    Beta:1.23
    Earnings Date:Mar 3 - Mar 9 (Est.)
    Day's Range:1.19 - 1.25
    52wk Range:1.07 - 5.19
    Volume:1,661,279
    Avg Vol (3m):1,968,180
    Market Cap:191.30M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ZGNXUp 4.17%191.30M
    AZNUp 0.67%89.56B
    GSKUp 0.70%103.73B
    PFEUp 0.73%199.42B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.17
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.67
    Quarterly EPS Est (Dec-14) :-0.11
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):-0.07

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company’s commercial product includes Zohydro, a single-entity extended-release hydrocodone for... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback